MedTrace Logo

Evaluation of the Impact of Tricuspid Regurgitation on Patients Lives. Exploration of Experience and Impact on a Daily Basis.

NCT05532956 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2022-09-08

No results posted yet for this study

Summary

The purpose of this study is to objectively assess the impact of the pathology on the patient's life so as to best inform the choices of evaluators "the French National Authority for Health" (HAS) and decision makers "the Economics Committee for Health Products" (CEPS) through the expression of the patients' feelings themselves.

For this, the study will assess the impact of severe tricuspid insufficiency and its symptoms on the quality of life of patients from a physical, psychological and social point of view.

Conditions

  • Severe Tricuspid Regurgitation Medically Treated and Not Operated (Without Valve Replacement or Repair)

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY

  • Gérond'if

    lead OTHER

Principal Investigators

  • Caroline BACLET-ROUSSEL · Psychologist, Project and Research Manager, Gérond'if

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2022-09-30
Completion
2022-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05532956 on ClinicalTrials.gov